Related Experiment Videos
Therapeutic peptides and peptidomimetics
T Kieber-Emmons1, R Murali, M I Greene
1Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104, USA.
Current Opinion in Biotechnology
|August 1, 1997
Summary
Peptidomimetics, created by cyclizing peptide backbones, offer a novel approach to small molecule drug design. This method aids in developing dual inhibitors by revealing receptor similarities, overcoming delivery challenges.
Area of Science:
- Medicinal Chemistry
- Drug Design
- Molecular Biology
Background:
- Peptidomimetics are crucial in small molecule drug design.
- Cyclization and aromatic modification of peptide backbones are effective mimetic strategies.
- Existing methods face delivery and formulation challenges.
Purpose of the Study:
- To explore the utility of peptidomimetics in drug discovery.
- To investigate the combination of design strategies with molecular libraries.
- To identify novel approaches for lead discovery and development of dual inhibitors.
Main Methods:
- Cyclization of peptide backbones.
- Modification with aromatic residues.
- Utilizing molecular libraries and rational design strategies.
Main Results:
- Peptidomimetics effectively mimic beta-turn structures.
- This approach reveals receptor similarities missed by endogenous ligands.
- Development of dual inhibitors is facilitated.
Conclusions:
- Peptidomimetics provide valuable insights for drug design.
- Combining rational design with molecular libraries is a viable strategy.
- This work advances lead discovery for complex therapeutic targets.